» Articles » PMID: 35834819

From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue

Overview
Journal J Med Chem
Specialty Chemistry
Date 2022 Jul 14
PMID 35834819
Authors
Affiliations
Soon will be listed here.
Abstract

Nicotinic acetylcholine receptors containing α9 subunits (α9*-nAChRs) are potential druggable targets arousing great interest for pain treatment alternative to opioids. Nonpeptidic small molecules selectively acting as α9*-nAChRs antagonists still remain an unattained goal. Here, through modifications of the cationic head and the ethylene linker, we have converted the 2-triethylammonium ethyl ether of 4-stilbenol (MG624), a well-known α7- and α9*-nAChRs antagonist, into some selective antagonists of human α9*-nAChR. Among these, the compound with cyclohexyldimethylammonium head () stands out for having no α7-nAChR agonist or antagonist effect along with very low affinity at both α7- and α3β4-nAChRs. At supra-micromolar concentrations, and the other selective α9* antagonists behaved as partial agonists at α9*-nAChRs with a very brief response, followed by rebound current once the application is stopped and the channel is disengaged. The small or null postapplication activity of ACh seems to be related to the slow recovery of the rebound current.

Citing Articles

New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.

Dallanoce C, Richter K, Stokes C, Papotto C, Andleeb H, Thakur G ACS Chem Neurosci. 2024; 15(4):827-843.

PMID: 38335726 PMC: 11274740. DOI: 10.1021/acschemneuro.3c00720.


Analogs of α-conotoxin PnIC selectively inhibit α7β2- over α7-only subtype nicotinic acetylcholine receptors via a novel allosteric mechanism.

George A, John S, Lucero L, Eaton J, Jaiswal E, Christensen S FASEB J. 2024; 38(1):e23374.

PMID: 38161283 PMC: 10782225. DOI: 10.1096/fj.202302079.


Pharmacological profiles and anti-inflammatory activity of pCN-diEPP and mCN-diEPP, new alpha9alpha10 nicotinic receptor ligands.

Richter K, Herz S, Stokes C, Damaj M, Grau V, Papke R Neuropharmacology. 2023; 240:109717.

PMID: 37758018 PMC: 11295495. DOI: 10.1016/j.neuropharm.2023.109717.


α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.

Shelukhina I, Siniavin A, Kasheverov I, Ojomoko L, Tsetlin V, Utkin Y Int J Mol Sci. 2023; 24(7).

PMID: 37047495 PMC: 10095066. DOI: 10.3390/ijms24076524.


Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).

Bavo F, Pallavicini M, Pucci S, Appiani R, Giraudo A, Oh H J Med Chem. 2022; 66(1):306-332.

PMID: 36526469 PMC: 9841521. DOI: 10.1021/acs.jmedchem.2c01256.

References
1.
Zoli M, Pucci S, Vilella A, Gotti C . Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors. Curr Neuropharmacol. 2017; 16(4):338-349. PMC: 6018187. DOI: 10.2174/1570159X15666170912110450. View

2.
Hone A, Whiteaker P, Christensen S, Xiao Y, Meyer E, McIntosh J . A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors. J Neurochem. 2009; 111(1):80-9. PMC: 2749889. DOI: 10.1111/j.1471-4159.2009.06299.x. View

3.
Cavallini G, MASSARANI E . [Further research on stilbene and diphenylethane derivatives; new synthetic antinicotinics. III..]. Farmaco Sci. 1954; 9(8):405-15. View

4.
Liang J, Tae H, Xu X, Jiang T, Adams D, Yu R . Dimerization of α-Conotoxins as a Strategy to Enhance the Inhibition of the Human α7 and α9α10 Nicotinic Acetylcholine Receptors. J Med Chem. 2020; 63(6):2974-2985. DOI: 10.1021/acs.jmedchem.9b01536. View

5.
Pucci S, Zoli M, Clementi F, Gotti C . α9-Containing Nicotinic Receptors in Cancer. Front Cell Neurosci. 2022; 15:805123. PMC: 8814915. DOI: 10.3389/fncel.2021.805123. View